首页> 外文期刊>Human gene therapy >Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
【24h】

Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.

机译:腺病毒5纤维35嵌合载体介导囊性纤维化原发性气道上皮细胞中的囊性纤维化跨膜电导调节因子缺陷的有效根尖矫正。

获取原文
获取原文并翻译 | 示例
           

摘要

In vivo gene transfer to the human respiratory tract by adenovirus serotype 5 (Ad5) vectors has revealed their limitations related to inefficient gene transfer, host antiviral response, and innate adenoviral toxicity. In the present work, we compared the cytotoxicity and efficiency of Ad5 and a chimeric Ad5F35 vector with respect to CFTR gene transfer to cystic fibrosis (CF) and non-CF human airway epithelial cells. We found that high doses of Ad5 vector had an adverse effect on the function of exogenous and endogenous CFTR. Results obtained with Ad5 capsid mutants suggested that the RGD motifs on the penton base capsomers were responsible for the negative effect on CFTR function. This negative interference did not result from a lower level of biosynthesis and/or altered cellular trafficking of the CFTR protein, but rather from an indirect mechanism of functional blockage of CFTR, related to the RGD integrin-mediated endocytic pathway of Ad5. No negative interference with CFTR was observed for Ad5F35, an Ad5-based vector pseudotyped with fibers from Ad35, a serotype that uses another cell entry pathway. In vitro, Ad5F35 vector expressing the GFP-tagged CFTR (Ad5F35-GFP-CFTR) showed a 30-fold higher efficiency of transduction and chloride channel correction in CFTR-deficient cells, compared with Ad5GFP-CFTR. Ex vivo, Ad5F35-GFP-CFTR had the capacity to transduce efficiently reconstituted airway epithelia from patients with CF (CF-HAE) via the apical surface, restored chloride channel function at relatively low vector doses, and showed relatively stable expression of GFP-CFTR for several weeks.
机译:腺病毒血清型5(Ad5)载体在体内向人呼吸道的基因转移已显示出其与无效基因转移,宿主抗病毒反应和先天腺病毒毒性有关的局限性。在目前的工作中,我们比较了Ad5和嵌合Ad5F35载体在CFTR基因转移到囊性纤维化(CF)和非CF人气道上皮细胞方面的细胞毒性和效率。我们发现高剂量的Ad5载体对外源和内源CFTR的功能有不利影响。用Ad5衣壳突变体获得的结果表明,戊烯碱基衣壳上的RGD基序对CFTR功能产生负面影响。这种负面干扰不是由于CFTR蛋白的生物合成水平降低和/或细胞运输改变,而是由于CFTR功能性阻断的间接机制引起的,该机制与RGD整合素介导的Ad5内吞途径有关。对于Ad5F35,没有观察到对CFTR的负面干扰,Ad5F35是一种基于Ad5的载体,使用来自Ad35的纤维进行假型化,该血清型使用另一种细胞进入途径。在体外,与Ad5GFP-CFTR相比,表达GFP标记的CFTR的Ad5F35载体(Ad5F35-GFP-CFTR)在CFTR缺陷型细胞中的转导和氯离子通道校正效率高30倍。在体外,Ad5F35-GFP-CFTR能够通过顶表面从CF(CF-HAE)患者转导有效重构的气道上皮,以较低的载体剂量恢复氯离子通道功能,并显示GFP-CFTR的相对稳定表达几个星期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号